Autolus Therapeutics Other Long Term Liabilities (Quarterly) Analysis

Autolus Therapeutics Plc (AUTL)

1.41 +0.04 (+2.92%) USD | NASDAQ | Jan 14, 11:02

View Other Long Term Liabilities (Quarterly) for AUTL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Biodexa Pharmaceuticals Plc	Upgrade
NuCana Plc	--
Mereo BioPharma Group Plc	Upgrade
Bicycle Therapeutics Plc	Upgrade
Adaptimmune Therapeutics Plc	Upgrade